What Can We Learn from Sex Differences in MS?
Abstract
:1. Introduction
1.1. Multiple Sclerosis
1.2. Males
1.3. Females
1.4. Fertility
1.5. Comorbidities
1.6. Neuroimaging
1.7. Inheritance
1.8. Pregnancy
1.9. Breastfeeding
1.10. Family Planning Issues
1.11. Contraception
1.12. Assisted Reproductive Technology (ART)/IVF
1.13. Sexual Dysfunction
1.14. Menopause
1.15. Menses
2. Summary
Funding
Data Availability Statement
Conflicts of Interest
References
- Walton, C.; King, R.; Rechtman, L.; Kaye, W.; Leray, E.; Marrie, R.A.; Robertson, N.; La Rocca, N.; Uitdehaag, B.; Van Der Mei, I.; et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult. Scler. J. 2020, 26, 1816–1821. [Google Scholar] [CrossRef]
- Siva, A. Asymptomatic MS. Clin. Neurol. Neurosurg. 2013, 115 (Suppl. 1), S1–S5. [Google Scholar] [CrossRef]
- Lebrun-Frenay, C.; Kantarci, O.; Siva, A.; Sormani, M.P.; Pelletier, D.; Okuda, D.T.; Azevedo, C.; Amato, M.P.; Bensa, C.; Berger, E.; et al. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event. Ann. Neurol. 2020, 88, 407–417. [Google Scholar] [CrossRef]
- Tremblett, H.; Marrie, R.A. The multiple sclerosis prodrome: Emerging evidence, challenges, and opportunities. Mult. Scler. 2021, 27, 6–12. [Google Scholar] [CrossRef] [PubMed]
- Lublin, F.D.; Reingold, S.C.; Cohen, J.A.; Cutter, G.R.; Sørensen, P.S.; Thompson, A.J.; Wolinsky, J.S.; Balcer, L.J.; Banwell, B.; Barkhof, F.; et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 2014, 83, 278–286. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Thompson, A.; Banwell, B.L.; Barkhof, F.; Carroll, W.M.; Coetzee, T.; Comi, G.; Correale, J.; Fazekas, F.; Filippi, M.; Freedman, M.S.; et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018, 17, 162–173. [Google Scholar] [CrossRef]
- Goodin, D.S.; Khankhanian, P.; Gourraud, P.-A.; Vince, N. The nature of genetic and environmental susceptibility to multiple sclerosis. PLoS ONE 2021, 16, e0246157. [Google Scholar] [CrossRef]
- Torkildsen, O.; Grytten, N.; Aarseth, J.; Myhr, K.-M.; Kampman, M.T. Month of birth as a risk factor for multiple sclerosis: An update. Acta Neurol. Scand. Suppl. 2012, 195, 58–62. [Google Scholar] [CrossRef] [PubMed]
- Dobson, R.; Giovannoni, G.; Ramagopalan, S. The month of birth effect in multiple sclerosis: Systematic review, meta-analysis and effect of latitude. J. Neurol. Neurosurg. Psychiatry 2012, 84, 427–432. [Google Scholar] [CrossRef] [PubMed]
- Villar-Quiles, R.N.; Matias-Guiu, J.A.; Ortega, G.; González-Suárez, I.; Oreja-Guevara, C.; Matías-Guiu, J. Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population. Eur. Neurol. 2016, 76, 202–209. [Google Scholar] [CrossRef]
- Safi, N.V.; Krieger, S. Men with Multiple Sclerosis. Pract. Neurol. 2021, February, 37–40. [Google Scholar]
- Golden, L.C.; Voskuhl, R. The importance of studying sex differences in disease: The example of multiple sclerosis. J. Neurosci. Res. 2016, 95, 633–643. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ribbons, K.A.; McElduff, P.; Boz, C.; Trojano, M.; Izquierdo, G.; Duquette, P.; Girard, M.; Grand’Maison, F.; Hupperts, R.; Grammond, P.; et al. Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS. PLoS ONE 2015, 10, e0122686. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pecori, C.; Giannini, M.; Portaccio, E.; Ghezzi, A.; Hakiki, B.; Pastò, L.; Razzolini, L.; Sturchio, A.; De Giglio, L.; Pozzilli, C.; et al. Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: A prospective observational multicentric study. BMC Neurol. 2014, 14, 114. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hellwig, K.; Haghikia, A.; Gold, R. Parenthood and immunomodulation in patients with multiple sclerosis. J. Neurol. 2010, 257, 580–583. [Google Scholar] [CrossRef]
- Kieseier, B.C.; Benamor, M. Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide During Treatment for Relapsing–Remitting Multiple Sclerosis. Neurol. Ther. 2014, 3, 133–138. [Google Scholar] [CrossRef] [Green Version]
- Lu, E.; Zhu, F.; Zhao, Y.; Van Der Kop, M.; Sadovnick, A.; Synnes, A.; Dahlgren, L.; Traboulsee, A.; Tremlett, H. Birth outcomes of pregnancies fathered by men with multiple sclerosis. Mult. Scler. J. 2014, 20, 1260–1264. [Google Scholar] [CrossRef] [PubMed]
- Glazer, C.H.; Tøttenborg, S.S.; Giwercman, A.; Bräuner, E.V.; Eisenberg, M.L.; Vassard, D.; Magyari, M.; Pinborg, A.; Schmidt, L.; Bonde, J.P. Male factor infertility and risk of multiple sclerosis: A register-based cohort study. Mult. Scler. J. 2018, 24, 1835–1842. [Google Scholar] [CrossRef]
- Brubaker, W.D.; Li, S.; Baker, L.C.; Eisenberg, M.L. Increased risk of autoimmune disorders in infertile men: Analysis of US claims data. Andrology 2018, 6, 94–98. [Google Scholar] [CrossRef] [Green Version]
- Chitnis, T. The role of testosterone in MS risk and course. Mult. Scler. J. 2018, 24, 36–41. [Google Scholar] [CrossRef] [Green Version]
- Bove, R.; Malik, M.T.; Diaz-Cruz, C.; Chua, A.; Saraceno, T.J.; Bargiela, D.; Greeke, E.; Glanz, B.I.; Healy, B.C.; Chitnis, T. The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS. Neurology 2015, 85, 1209–1213. [Google Scholar] [CrossRef] [Green Version]
- Sicotte, N.L.; Giesser, B.S.; Tandon, V.; Klutch, R.; Steiner, B.; Drain, A.E.; Shattuck, D.W.; Hull, L.; Wang, H.; Voskuhl, R.R.; et al. Testosterone treatment in multiple sclerosis: A pilot study. Arch. Neurol. 2007, 64, 683–688. [Google Scholar] [CrossRef] [Green Version]
- Magyari, M.; Sorensen, P.S. The changing course of multiple sclerosis: Rising incidence, change in geographic distribution, disease course, and prognosis. Curr. Opin. Neurol. 2019, 32, 320–326. [Google Scholar] [CrossRef] [PubMed]
- Koch-Henriksen, N.; Thygesen, L.C.; Stenager, E.; Laursen, B.; Magyari, M. Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women. Neurology 2018, 90, e1954–e1963. [Google Scholar] [CrossRef]
- Murtonen, A.; Sumelahti, M. Multiple sclerosis prevalence in 2000 and 2010 in Western Finland. Acta Neurol. Scand. 2020, 141, 311–318. [Google Scholar] [CrossRef] [PubMed]
- Westerlind, H.; Stawiarz, L.; Fink, K.; Hillert, J.; Manouchehrinia, A. A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study. Mult. Scler. J. 2016, 22, 1071–1079. [Google Scholar] [CrossRef]
- Sepúlveda, M.; Ros, C.; Martínez-Lapiscina, E.H.; Solà-Valls, N.; Hervàs, M.; Llufriu, S.; La Puma, D.; Casals, E.; Blanco, Y.; Villoslada, P.; et al. Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study. Mult. Scler. J. 2016, 22, 564–568. [Google Scholar] [CrossRef] [PubMed]
- Thöne, J.; Kollar, S.; Nousome, D.; Ellrichmann, G.; Kleiter, I.; Gold, R.; Hellwig, K. Serum anti-Müllerian hormone levels in reproductive-age women with relapsing–remitting multiple sclerosis. Mult. Scler. J. 2015, 21, 41–47. [Google Scholar] [CrossRef] [PubMed]
- Thöne, J.; Kleiter, I.; Stahl, A.; Ellrichmann, G.; Gold, R.; Hellwig, K. Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis. J. Neurol. Sci. 2016, 362, 240–243. [Google Scholar] [CrossRef]
- Cil, A.P.; Leventoğlu, A.; Sönmezer, M.; Soylukoç, R.; Oktay, K. Assessment of ovarian reserve and Doppler characteristics in patients with multiple sclerosis using immunomodulating drugs. J. Turk. Gynecol. Assoc. 2009, 10, 213–219. [Google Scholar]
- Graves, J.S.; Henry, R.G.; Cree, B.A.; Lambert-Messerlian, G.; Greenblatt, R.M.; Waubant, E.; Cedars, M.I.; Zhu, A.; Bacchetti, P.; Hauser, S.L.; et al. Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology 2018, 90, e254–e260. [Google Scholar] [CrossRef]
- Marrie, R.A.; Rudick, R.; Horwitz, R.; Cutter, G.; Tyry, T.; Campagnolo, D.; Vollmer, T. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010, 74, 1041–1047. [Google Scholar] [CrossRef] [Green Version]
- Marrie, R.A.; Patten, S.B.; Tremlett, H.; Wolfson, C.; Warren, S.; Svenson, L.W.; Jette, N.; Fisk, J. Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study. Neurology 2016, 86, 1279–1286. [Google Scholar] [CrossRef] [Green Version]
- McKay, K.A.; Tremlett, H.; Fisk, J.D.; Zhang, T.; Patten, S.B.; Kastrukoff, L.; Campbell, T.; Marrie, R.A. For the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology 2018, 90, e1316–e1323. [Google Scholar] [CrossRef] [PubMed]
- Kanaan, R.A.; Allin, M.; Picchioni, M.; Barker, G.; Daly, E.; Shergill, S.; Woolley, J.; McGuire, P. Gender Differences in White Matter Microstructure. PLoS ONE 2012, 7, e38272. [Google Scholar] [CrossRef] [PubMed]
- Ingalhalikar, M.; Smith, A.; Parker, D.; Satterthwaite, T.D.; Elliott, M.A.; Ruparel, K.; Hakonarson, H.; Gur, R.E.; Gur, R.C.; Verma, R. P Sex differences in the structural connectome of the human brain. Proc. Natl. Acad. Sci. USA 2014, 111, 823–828. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fazekas, F.; Enzinger, C.; Wallner-Blazek, M.; Ropele, S.; Pluta-Fuerst, A.; Fuchs, S. Gender differences in MRI studies on multiple sclerosis. J. Neurol. Sci. 2009, 286, 28–30. [Google Scholar] [CrossRef] [PubMed]
- Costello, F.; Hodge, W.; Pan, Y.I.; Burton, J.M.; Freedman, M.S.; Stys, P.K.; Trufyn, J.; Kardon, R. Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis. Neurology 2012, 79, 1866–1872. [Google Scholar] [CrossRef] [Green Version]
- Antulov, R.; Weinstock-Guttman, B.; Cox, J.L.; Hussein, S.; Durfee, J.; Caiola, C.; Dwyer, M.; Bergsland, N.; Abdelrahman, N.; Stosic, M.; et al. Gender-related differences in MS: A study of conventional and nonconventional MRI measures. Mult. Scler. J. 2009, 15, 345–354. [Google Scholar] [CrossRef]
- Voskuhl, R.R.; Patel, K.; Paul, F.; Gold, S.M.; Scheel, M.; Kuchling, J.; Cooper, G.; Asseyer, S.; Chien, C.; Brandt, A.U.; et al. Sex differences in brain atrophy in multiple sclerosis. Biol. Sex Differ. 2020, 11, 49. [Google Scholar] [CrossRef] [PubMed]
- Klistorner, A.; Wang, C.; Yiannikas, C.; Graham, S.; Parratt, J.; Barnett, M.H. Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study. PLoS ONE 2016, 11, e0149245. [Google Scholar] [CrossRef] [Green Version]
- O’Gorman, C.; Lin, R.; Stankovich, J.; Broadley, S.A. Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data. Neuroepidemiology 2013, 40, 1–12. [Google Scholar] [CrossRef] [Green Version]
- Sandberg-Wollheim, M.; Neudorfer, O.; Grinspan, A.; Weinstock-Guttman, B.; Haas, J.; Izquierdo, G.; Riley, C.; Ross, A.P.; Baruch, P.; Drillman, T.; et al. Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy Database. Int. J. MS Care 2018, 20, 9–14. [Google Scholar] [CrossRef] [Green Version]
- Coyle, P.K. Management of women with multiple sclerosis through pregnancy and after childbirth. Ther. Adv. Neurol. Disord. 2016, 9, 198–210. [Google Scholar] [CrossRef] [Green Version]
- Coyle, P.K.; Oh, J.; Magyari, M.; Oreja-Guevara, C.; Houtchens, M. Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review. Mult. Scler. Relat. Disord. 2019, 32, 54–63. [Google Scholar] [CrossRef] [Green Version]
- Comi, G.; Hartung, H.-P.; Bakshi, R.; Williams, I.M.; Wiendl, H. Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis. Drugs 2017, 77, 1755–1768. [Google Scholar] [CrossRef]
- Guarnaccia, J.B.; Cabot, A.; Garten, L.; Napoli, S.Q.; Hasbani, M.J. Teriflunomide Levels in Women Whose Male Sexual Partner Is on Teriflunomide for Relapsing Multiple Sclerosis. In ACTRIMS Forum 2019; ACTRIMS: Dallas, TX, USA, 2019; p. 115. [Google Scholar]
- Portaccio, E.; Tudisco, L.; Pastò, L.; Razzolini, L.; Fonderico, M.; Bellinvia, A.; Ghezzi, A.; Annovazzi, P.; Zaffaroni, M.; Moiola, L.; et al. Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening. Mult. Scler. J. 2021. [Google Scholar] [CrossRef]
- Confavreux, C.; Hutchinson, M.; Hours, M.M.; Cortinovis-Tourniaire, P.; Moreau, T. Rate of Pregnancy-Related Relapse in Multiple Sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 1998, 339, 285–291. [Google Scholar] [CrossRef] [PubMed]
- E Hughes, S.; Spelman, T.; Gray, O.M.; Boz, C.; Trojano, M.; Lugaresi, A.; Izquierdo, G.; Duquette, P.; Girard, M.; Grand’Maison, F.; et al. Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult. Scler. J. 2014, 20, 739–746. [Google Scholar] [CrossRef] [PubMed]
- Langer-Gould, A.; Smith, J.B.; Albers, K.B.; Xiang, A.H.; Wu, J.; Kerezsi, E.H.; McClearnen, K.; Gonzales, E.G.; Leimpeter, A.D.; Eeden, S.K.V.D. Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort. Neurology 2020, 94, e1939–e1949. [Google Scholar] [CrossRef] [PubMed]
- Dobson, R.; Jokubaitis, V.G.; Giovannoni, G. Change in pregnancy-associated multiple sclerosis relapse rates over time: A meta-analysis. Mult. Scler. Relat. Disord. 2020, 44, 102241. [Google Scholar] [CrossRef]
- Alroughani, R.; Akhtar, S.; Zeineddine, M.; Kouzi, Y.E.; El Ayoubi, N.K.; Ahmed, S.F.; Behbehani, R.; Khoury, S.J.; Al-Hashel, J.Y.; Yamout, B.I. Risk of relapses during pregnancy among multiple sclerosis patients. Mult. Scler. Relat. Disord. 2019, 34, 9–13. [Google Scholar] [CrossRef]
- Bandoli, G.; Palmsten, K.; Smith, C.J.F.; Chambers, C.D. A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes. Rheum. Dis. Clin. N. Am. 2017, 43, 489–502. [Google Scholar] [CrossRef]
- Hviid, A.; Mølgaard-Nielsen, D. Corticosteroid use during pregnancy and risk of orofacial clefts. Can. Med Assoc. J. 2011, 183, 796–804. [Google Scholar] [CrossRef] [Green Version]
- Krysko, K.M.; Rutatangwa, A.; Graves, J.; Lazar, A.; Waubant, E. Association between Breastfeeding and Postpartum Multiple Sclerosis Relapses: A Systematic Review and Meta-analysis. JAMA Neurol. 2020, 77, 327–338. [Google Scholar] [CrossRef] [PubMed]
- Langer-Gould, A.; Smith, J.B.; Hellwig, K.; Gonzales, E.; Haraszti, S.; Koebnick, C.; Xiang, A. Breastfeeding, ovulatory years, and risk of multiple sclerosis. Neurology 2017, 89, 563–569. [Google Scholar] [CrossRef] [PubMed]
- Brenton, J.N.; Engel, C.E.; Sohn, M.-W.; Goldman, M.D. Breastfeeding during Infancy Is Associated with a Lower Future Risk of Pediatric Multiple Sclerosis. Pediatr. Neurol. 2017, 77, 67–72. [Google Scholar] [CrossRef] [PubMed]
- Hedström, A.K.; Adams, C.; Shao, X.; Schaefer, C.; Olsson, T.; Barcellos, L.F.; Alfredsson, L. Breastfeeding is associated with reduced risk of multiple sclerosis in males, predominantly among HLA-DRB1*15:01 carriers. Mult. Scler. J.—Exp. Transl. Clin. 2020, 6, 2055217320928101. [Google Scholar] [CrossRef] [PubMed]
- Rae-Grant, A.; Day, G.S.; Marrie, R.A.; Rabinstein, A.; Cree, B.A.; Gronseth, G.S.; Haboubi, M.; Halper, J.; Hosey, J.P.; Pringsheim, T.; et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2018, 90, 777–788. [Google Scholar] [CrossRef] [Green Version]
- Houtchens, M.K.; Zapata, L.B.; Curtis, K.M.; Whiteman, M.K. Contraception for women with multiple sclerosis: Guidance for healthcare providers. Mult. Scler. J. 2017, 23, 757–764. [Google Scholar] [CrossRef] [Green Version]
- Yland, J.J.; A Bresnick, K.; E Hatch, E.; Wesselink, A.K.; Mikkelsen, E.M.; Rothman, K.J.; Sørensen, H.T.; Huybrechts, K.F.; A Wise, L. Pregravid contraceptive use and fecundability: Prospective cohort study. BMJ 2020, 371, m3966. [Google Scholar] [CrossRef]
- Bove, R.; Rankin, K.; Lin, C.; Zhao, C.; Correale, J.; Hellwig, K.; Michel, L.; A Laplaud, D.; Chitnis, T. Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis. Mult. Scler. J. 2020, 26, 1410–1419. [Google Scholar] [CrossRef]
- Bove, R.; Okai, A.; Houtchens, M.; Elias-Hamp, B.; Lugaresi, A.; Hellwig, K.; Havrdová, E.K. Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review. Front. Neurol. 2021, 12, 554375. [Google Scholar] [CrossRef] [PubMed]
- Singh, P. Andropause: Current concepts. Indian J. Endocrinol. Metab. 2013, 17 (Suppl. 3), S621–S629. [Google Scholar] [CrossRef] [PubMed]
- Roeder, H.J.; Leira, E.C. Effects of the Menstrual Cycle on Neurological Disorders. Curr. Neurol. Neurosci. Rep. 2021, 21, 34. [Google Scholar] [CrossRef]
- Dubol, M.; Epperson, C.N.; Sacher, J.; Pletzer, B.; Derntl, B.; Lanzenberger, R.; Sundström-Poromaa, I.; Comasco, E. Neuroimaging the menstrual cycle: A multimodal systematic review. Front. Neuroendocrinol. 2021, 60, 100878. [Google Scholar] [CrossRef] [PubMed]
- Wingerchuk, D.M.; Rodriguez, M. Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin. Arch. Neurol. 2006, 63, 1005–1008. [Google Scholar] [CrossRef] [Green Version]
- Mirmosayyeb, O.; Badihian, S.; Manouchehri, N.; Basiri, A.K.; Barzegar, M.; Esmaeil, N.; Fayyazi, E.; Shaygannejad, V. The interplay of multiple sclerosis and menstrual cycle: Which one affects the other one? Mult. Scler. Relat. Disord. 2018, 21, 46–50. [Google Scholar] [CrossRef] [PubMed]
- Yorgun, Y.G.; Ozakbas, S. Effect of hormonal changes on the neurological status in the menstrual cycle of patient with multiple sclerosis. Clin. Neurol. Neurosurg. 2019, 186, 105499. [Google Scholar] [CrossRef]
|
Asymptomatic |
|
Symptomatic |
|
|
|
|
|
|
Genetics |
|
Environmental |
|
Immunologic |
|
|
|
|
Injectables |
|
|
|
|
Orals |
|
|
|
|
|
|
|
|
Monoclonals |
|
|
|
|
|
|
Chemotherapeutics |
|
|
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Coyle, P.K. What Can We Learn from Sex Differences in MS? J. Pers. Med. 2021, 11, 1006. https://doi.org/10.3390/jpm11101006
Coyle PK. What Can We Learn from Sex Differences in MS? Journal of Personalized Medicine. 2021; 11(10):1006. https://doi.org/10.3390/jpm11101006
Chicago/Turabian StyleCoyle, Patricia K. 2021. "What Can We Learn from Sex Differences in MS?" Journal of Personalized Medicine 11, no. 10: 1006. https://doi.org/10.3390/jpm11101006
APA StyleCoyle, P. K. (2021). What Can We Learn from Sex Differences in MS? Journal of Personalized Medicine, 11(10), 1006. https://doi.org/10.3390/jpm11101006